Letter to the Editor. Cost-effectiveness of sodium fluorescein in high-grade gliomas

View More View Less
  • San Bortolo Hospital, Vicenza, Italy
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

If the inline PDF is not rendering correctly, you can download the PDF file here.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Correspondence Oriela Rustemi: orielarustemi@libero.it.

INCLUDE WHEN CITING Published online December 13, 2019; DOI: 10.3171/2019.10.JNS192817.

Disclosures The authors report no conflict of interest.

  • 1

    Della Puppa A, Lombardi G, Rossetto M, Rustemi O, Berti F, Cecchin D, : Outcome of patients affected by newly diagnosed glioblastoma undergoing surgery assisted by 5-aminolevulinic acid guided resection followed by BCNU wafers implantation: a 3-year follow-up. J Neurooncol 131:331340, 2017

    • Search Google Scholar
    • Export Citation
  • 2

    Della Puppa A, Rustemi O, Rampazzo E, Persano L: Combining 5-aminolevulinic acid fluorescence and intraoperative magnetic resonance imaging in glioblastoma surgery: a histology-based evaluation. Neurosurgery 80:E188E190, 2017 (Letter)

    • Search Google Scholar
    • Export Citation
  • 3

    Hansen RW, Pedersen CB, Halle B, Korshoej AR, Schulz MK, Kristensen BW, : Comparison of 5-aminolevulinic acid and sodium fluorescein for intraoperative tumor visualization in patients with high-grade gliomas: a single-center retrospective study. J Neurosurg [epub ahead of print October 4, 2019. DOI: 10.3171/2019.6.JNS191531]

    • Search Google Scholar
    • Export Citation
  • 4

    Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ: Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392401, 2006

    • Search Google Scholar
    • Export Citation
  • 1

    Acerbi F, Broggi M, Schebesch KM, Höhne J, Cavallo C, De Laurentis C, : Fluorescein-guided surgery for resection of high-grade gliomas: a multicentric prospective phase II study (FLUOGLIO). Clin Cancer Res 24:5261, 2018

    • Search Google Scholar
    • Export Citation
  • 2

    Barone F, Alberio N, Iacopino DG, Giammalva GR, D’Arrico C, Tagnese W, : Brain mapping as helpful tool in brain glioma surgical treatment toward the “perfect surgery”? Brain Sci 8:192, 2018

    • Search Google Scholar
    • Export Citation
  • 3

    Diaz RJ, Dios RR, Hattab EM, Burrell K, Rakopoulos P, Sabha N, : Study of the biodistribution of fluorescein in glioma-infiltrated mouse brain and histopathological correlation of intraoperative findings in high-grade gliomas resected under fluorescein fluorescence guidance. J Neurosurg 122:13601369, 2015

    • Search Google Scholar
    • Export Citation
  • 4

    Schwake M, Stummer W, Suero Molina EJ, Wolfer J: Simultaneous fluorescein sodium and 5-ALA in fluorescence-guided glioma surgery. Acta Neurochir (Wien) 157:877879, 2015

    • Search Google Scholar
    • Export Citation
  • 5

    Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ: Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392401, 2006

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 44 44 32
Full Text Views 21 21 19
PDF Downloads 24 24 23
EPUB Downloads 0 0 0